Pain medicine was represented at the recent American Medical Association House of Delegates (HOD) Annual Meeting by AAPM delegate Robert Wailes, MD , and alternate delegate Donna Bloodworth, MD . Among topics discussed, ...
Content in this section will include AAPM advocacy efforts, legislative news, public statements, etc.
RXQ Compounding, LLC ("RXQ") is voluntarily recalling all sterile human and animal products within expiry to the user level due to lack of sterility process assurance associated with the production of the Company's...
The recommendations include tangible actions policymakers can take to help reduce barriers to evidence-based treatment and end the nation's opioid epidemic. AAPM is among the 25 specialty and state medical societies that...
A new controlled substance law in Florida has helped to decrease opioid prescriptions after outpatient surgery, according to a retrospective analysis at a large academic center. Full story.
An Oregon committee has abandoned a controversial proposal that would have expanded treatment options for chronic pain patients under the Oregon Health Plan, but would have forced many to reduce dosages or discontinue pr...
The Evidence-based Practice Center (EPC) Program at the Agency for Healthcare Research and Quality (AHRQ) has posted the draft report for the systematic review on Comparative Effectiveness of Analgesics to Reduce Acute P...
Vanila M. Singh, MD MACM, Chairperson of the HHS Pain Management Inter-Agency Task Force, is interviewed about the task force's recommendations for treating acute and chronic pain. Full story.
An Oregon committee has abandoned a controversial proposal that would have expanded treatment options for chronic pain patients under the Oregon Health Plan, but would have forced many to reduce dosages or discontinue prescription opioids.
Association of American Medical Colleges President and CEO Darrell G. Kirch, MD, issued a statement about the Opioid Workforce Act of 2019 (H.R. 2439), which was introduced in the U.S. House of Representatives and would support new addiction medicine, addiction psychiatry, or pain management residency positions.
FDA is seeking public input on the clinical utility and safety concerns associated with the higher range of opioid analgesic dosing (both in terms of higher strength products and higher daily doses) in the outpatient set...